Clinical Trial Update: Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating consolidation therapy with bevacizumab (Avastin) with or without erlotinib after induction chemotherapy in advanced ovarian, fallopia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Mullerian Tumor
• Fallopian Tube Cancer
• Ovarian Cancer
• Papillary Serous Mullerian Tumor
• Peritoneal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-07-03